A detailed history of Steph & CO transactions in Amgen Inc stock. As of the latest transaction made, Steph & CO holds 27 shares of AMGN stock, worth $8,532. This represents 0.0% of its overall portfolio holdings.

Number of Shares
27
Holding current value
$8,532
% of portfolio
0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

BUY
$309.38 - $337.38 $8,353 - $9,109
27 New
27 $8,000
Q3 2023

Oct 26, 2023

BUY
$218.65 - $271.46 $14,868 - $18,459
68 New
68 $18,000
Q3 2020

Oct 27, 2020

SELL
$234.65 - $260.95 $117,325 - $130,475
-500 Closed
0 $0
Q4 2019

Feb 24, 2020

BUY
$189.21 - $243.2 $94,605 - $121,600
500 New
500 $121,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Steph & CO Portfolio

Follow Steph & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Steph & CO, based on Form 13F filings with the SEC.

News

Stay updated on Steph & CO with notifications on news.